E

Elan Corp
TSE:6099

Watchlist Manager
Elan Corp
TSE:6099
Watchlist
Price: 738 JPY -0.4% Market Closed
Market Cap: 44.7B JPY
Have any thoughts about
Elan Corp?
Write Note
Section:
 

Relative Value

The Relative Value of one Elan Corp stock under the Base Case scenario is 1 384.15 JPY. Compared to the current market price of 738 JPY, Elan Corp is Undervalued by 47%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
1 384.15 JPY
Undervaluation 47%
Relative Value
Price
E
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
98
vs Industry
62
Median 3Y
1.6
Median 5Y
1.9
Industry
2.3
Forward
0.9
More Details
18.1
P/E
P/E
Price to Earnings
18.1
vs History
98
vs Industry
26
Median 3Y
27.2
Median 5Y
31.6
Industry
23.2
Forward
15.5
More Details
26.1
P/OCF
P/OCF
Price to OCF
26.1
vs History
93
vs Industry
12
Median 3Y
30.8
Median 5Y
35.9
Industry
14.3
More Details
33.3
P/FCFE
P/FCFE
Price to FCFE
33.3
vs History
80
vs Industry
17
Median 3Y
36.8
Median 5Y
40.2
Industry
20.1
More Details
3.8
P/B
P/B
Price to Book Value
3.8
vs History
98
vs Industry
16
Median 3Y
6.2
Median 5Y
8.1
Industry
2.2
More Details
0.9
EV/S
EV/S
Enterprise Value to Sales
0.9
vs History
98
vs Industry
64
Median 3Y
1.4
Median 5Y
1.7
Industry
2.4
Forward
0.8
More Details
3.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.9
vs History
98
vs Industry
44
Median 3Y
6
Median 5Y
6.9
Industry
5
More Details
10.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.1
vs History
98
vs Industry
27
Median 3Y
15.2
Median 5Y
18.9
Industry
12.8
Forward
9.1
More Details
11.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
11.2
vs History
98
vs Industry
32
Median 3Y
15.9
Median 5Y
19.7
Industry
17.2
More Details
23.9
EV/OCF
EV/OCF
Enterprise Value to OCF
23.9
vs History
90
vs Industry
14
Median 3Y
28.3
Median 5Y
33.4
Industry
14
More Details
30.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
30.5
vs History
80
vs Industry
15
Median 3Y
32.9
Median 5Y
37.2
Industry
18.2
More Details
4.3
EV/IC
EV/IC
Enterprise Value to IC
4.3
vs History
98
vs Industry
12
Median 3Y
10.1
Median 5Y
14.8
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Elan Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Elan Corp
TSE:6099
44.6B JPY 1 18.1 10.1 11.2
US
Cigna Group
XMUN:CGN
75B EUR 0.3 25.7 8 10.4
US
Cigna Corp
NYSE:CI
77.2B USD 0.3 25.4 8 10.3
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.9B EUR 1.3 39.2 10.7 23.1
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.9B EUR 0.9 -49.3 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.2B USD 1.5 44.1 13.2 20.3
US
R1 RCM Inc
NASDAQ:RCM
17.7B USD 7.2 -289.7 38.3 99.1
US
Quest Diagnostics Inc
NYSE:DGX
16.9B USD 1.8 20.2 12.2 16.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 19.7 6.6 14.3
US
DaVita Inc
NYSE:DVA
12.4B USD 1 14.9 7.8 10.9
P/E Multiple
Earnings Growth PEG
JP
E
Elan Corp
TSE:6099
Average P/E: 24.3
18.1
20%
0.9
US
C
Cigna Group
XMUN:CGN
25.7
25%
1
US
Cigna Corp
NYSE:CI
25.4
25%
1
US
CVS Health Corp
NYSE:CVS
11.3
3%
3.8
DE
Fresenius Medical Care AG
XMUN:FME
39.2
31%
1.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49.3 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.1
54%
0.8
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -289.7
253%
N/A
US
Quest Diagnostics Inc
NYSE:DGX
20.2
12%
1.7
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
19.7
31%
0.6
US
DaVita Inc
NYSE:DVA
14.9
17%
0.9

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 212,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.